OncoCyte Corporation
OCX
$2.84
$0.010.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.44% | -76.36% | -48.28% | -54.86% | -53.82% |
| Total Receivables | 233.26% | -88.89% | -95.05% | -91.53% | -75.94% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 27.68% | -6.70% | -49.53% | -24.23% | -34.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 100.72% | 160.43% | -83.25% | -85.51% | -93.45% |
| Total Current Assets | 9.92% | -71.67% | -52.50% | -58.24% | -58.11% |
|
|
|||||
| Total Current Assets | 9.92% | -71.67% | -52.50% | -58.24% | -58.11% |
| Net Property, Plant & Equipment | 16.34% | 11.35% | -24.72% | -32.02% | -49.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -74.19% | -0.16% | -0.16% | -0.16% | -8.17% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.54% | 8.06% | 11.53% | 3.43% | 4.44% |
| Total Assets | -53.16% | -13.94% | -14.64% | -14.28% | -25.18% |
|
|
|||||
| Total Accounts Payable | 139.14% | -23.24% | 20.11% | -34.91% | -23.94% |
| Total Accrued Expenses | 7.96% | 9.36% | -19.82% | -6.89% | -42.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 94.74% | 78.19% | 39.62% | 5.94% | -18.40% |
| Total Finance Division Other Current Liabilities | -90.33% | 16.51% | -9.54% | -12.97% | -46.73% |
| Total Other Current Liabilities | -90.33% | 16.51% | -9.54% | -12.97% | -46.73% |
| Total Current Liabilities | 1.13% | 13.16% | -6.12% | -11.70% | -40.57% |
|
|
|||||
| Total Current Liabilities | 1.13% | 13.16% | -6.12% | -11.70% | -40.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.49% | 15.04% | 10.01% | -1.41% | -19.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -5.49% | 69.62% | 44.70% | 57.97% | -12.62% |
| Total Liabilities | -3.94% | 54.74% | 32.65% | 37.42% | -18.51% |
|
|
|||||
| Common Stock & APIC | 9.01% | 5.38% | 5.38% | 5.08% | 5.21% |
| Retained Earnings | -20.93% | -16.36% | -14.12% | -16.05% | -11.20% |
| Treasury Stock & Other | -57.14% | 78.13% | -9.76% | -6.98% | 25.64% |
| Total Common Equity | -159.97% | -74.15% | -47.93% | -69.45% | -40.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -3.62% | -3.32% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -3.62% | -3.32% |
|
|
|||||
| Total Common Equity | -159.97% | -74.15% | -47.93% | -69.45% | -40.31% |
| Total Preferred Equity | -- | -- | -- | -3.62% | -3.32% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -147.96% | -77.14% | -53.02% | -61.07% | -35.36% |
|
|
|||||